SIBO NATUROPATH · MAROOCHYDORE, SUNSHINE COAST & TELEHEALTH

Why SIBO Keeps Coming Back


A considered approach to recurrence, incomplete response and persistent digestive symptoms

You completed treatment, changed your diet and finally began to feel better.

Then the bloating returned. Foods became difficult again. Constipation, diarrhoea or abdominal discomfort gradually crept back in.

It is understandable to assume that the SIBO has returned.

Sometimes it has. But recurring symptoms do not automatically confirm recurring SIBO or intestinal methanogen overgrowth.

Several different situations can look like relapse:

  • The original overgrowth may not have fully resolved

  • SIBO or IMO may have genuinely returned

  • Another digestive condition may now be producing similar symptoms

That distinction matters because repeating the same antimicrobial treatment is not always the most useful next step.

SIBO can recur after apparently successful treatment. Observational studies have reported recurrence in approximately 40% of patients within six to nine months, with ongoing predisposing conditions, previous abdominal surgery, older age and long-term proton-pump inhibitor use among the associated factors. The risk for an individual patient is less predictable.

I work with people experiencing recurrent bloating, constipation, diarrhoea, food restriction and persistent symptoms following previous SIBO or IMO treatment.

Consultations are available in Maroochydore and at Kunara Marketplace in Forest Glen on the Sunshine Coast, as well as by Telehealth throughout Australia.

Request an initial consultation

Learn more about SIBO symptoms, testing and treatment support

Three situations that can look like SIBO relapse

01

The original overgrowth may not have fully resolved

Symptoms may improve during treatment without completely resolving, particularly when gas levels were high, treatment was not tolerated or the original diagnosis was uncertain.

This may represent an incomplete response rather than a new relapse.

02

SIBO or IMO may have returned

You may have improved substantially and remained well for weeks or months before the same symptom pattern gradually returned.

Repeat testing may be useful when the result would change the next treatment decision.

03

Another condition may be causing similar symptoms

Bloating, constipation, diarrhoea and food sensitivity are not specific to SIBO.

IBS, constipation, pelvic-floor dysfunction, food intolerances or another digestive concern may now better explain the symptoms.

The return of a symptom is not, by itself,
proof that the original diagnosis has returned.

Why confirmed SIBO or IMO can recur

SIBO is not simply a matter of eating the wrong foods or having “bad bacteria.”

The small intestine has several protective mechanisms that normally limit excessive microbial accumulation. These include coordinated motility, gastric acid, pancreatic and biliary secretions, intestinal anatomy and local immune defences. Problems affecting one or more of these systems can increase susceptibility in selected patients.

The most relevant factor is not the same for everyone.

Woman sitting in chair thinking

Small-intestinal motility and the migrating motor complex

Between meals, the digestive tract produces waves of coordinated movement known as the migrating motor complex, or MMC.

This interdigestive activity helps move residual material and microorganisms through the small intestine. Reduced motility or intestinal stasis can make overgrowth more likely.

This is one of the most clinically useful themes within Allison Siebecker’s teaching. She places particular emphasis on the MMC while also recognising that structural restrictions, medical conditions and other factors may impair intestinal clearance.

Factors that may affect motility include:

  • Previous gastrointestinal infection

  • Diabetes or other conditions affecting enteric nerves

  • Hypothyroidism

  • Certain medications, including opioid medicines

  • Gastroparesis or another motility disorder

  • Altered intestinal anatomy

  • Severe or longstanding constipation

In selected cases, management after treatment may include attention to meal timing or the use of a prokinetic.

However, the evidence for prokinetics specifically preventing SIBO recurrence remains limited. Consensus guidance describes this as plausible but supported by low-quality evidence rather than a guaranteed prevention strategy.

Meal spacing should also not become rigid fasting at the expense of adequate nutrition. The appropriate approach depends on appetite, weight, blood-glucose needs, medications and the wider health picture.

Constipation and intestinal methanogen overgrowth

Methane-positive breath testing is now described as intestinal methanogen overgrowth, or IMO, rather than methane-dominant SIBO.

Methanogens are archaea rather than bacteria, and they may be present in the small or large intestine.

IMO is associated with a higher prevalence and severity of constipation. A recent systematic review found that people with IMO were approximately twice as likely to experience constipation as those without it.

When methane and constipation are part of the presentation, the relapse plan should not focus only on reducing microorganisms.It may also need to consider:

  • Stool frequency and consistency

  • Incomplete evacuation

  • Slow colonic transit

  • Pelvic-floor dysfunction

  • Fibre and fluid tolerance

  • Medication effects

  • Long-term bowel management

If constipation remains unchanged, repeating antimicrobial treatment alone may provide only temporary improvement.

Read more about Intestinal Methanogen Overgrowth

Read more about Constipation Support

Previous gastroenteritis and post-infectious patterns

Some people can identify a clear turning point after food poisoning, traveller’s diarrhoea or another episode of infectious gastroenteritis.

Acute gastroenteritis is a recognised trigger for post-infectious IBS. Research has also explored whether immune responses involving anti-CdtB and anti-vinculin antibodies may contribute to altered motility and SIBO in a subset of patients, although this pathway should not be assumed in every case.

A history of infection is therefore clinically relevant, particularly when digestive symptoms began within the following months.

It does not automatically prove:

  • permanent nerve damage

  • that every subsequent symptom is recurrent SIBO

  • that specialised antibody testing is required

  • that the condition cannot be improved

The infection history is one part of the assessment, not a complete diagnosis.

Structural and anatomical factors

Previous abdominal or pelvic surgery, intestinal strictures, diverticula, adhesions or altered gastrointestinal anatomy can sometimes affect movement through the small intestine.

Prior abdominal surgery has been associated with SIBO recurrence in observational research.

This may be more relevant when symptoms began after:

  • Abdominal or pelvic surgery

  • Bowel surgery

  • Appendicitis

  • Significant abdominal inflammation

  • Radiation treatment

  • A known structural gastrointestinal condition

A symptom history cannot diagnose adhesions or mechanical obstruction.

Where the history raises a structural concern, medical imaging or gastroenterology assessment may be required alongside naturopathic care.

You do not need to complete that investigation before booking. I can assess the pattern, review previous reports and help clarify whether further referral is appropriate.

Do low stomach acid or poor bile flow cause relapse?

Gastric acid and pancreatic and biliary secretions are part of the body’s normal protection against microbial overgrowth. Reduced function can be relevant in specific medical contexts.

However, symptoms such as:

  • Belching

  • Early fullness

  • Heaviness after eating

  • Reflux

  • Nausea

  • Poor tolerance of fatty foods

  • Bloating after protein

do not diagnose low stomach acid, pancreatic insufficiency or impaired bile flow.

These symptoms have many possible explanations.

Empirically prescribing stomach acid, bile products or digestive enzymes based on symptoms alone can lead to inappropriate treatment and may aggravate reflux, gastritis or other conditions.

These areas should only become treatment priorities when the wider history provides a credible reason to investigate them.

Stress can affect symptoms without being the entire cause

Stress can influence sleep, eating patterns, bowel function, visceral sensitivity and how intensely digestive sensations are experienced.

That makes stress support clinically relevant for some patients.

It does not mean:

  • SIBO is psychological

  • anxiety created the overgrowth

  • nervous-system exercises will reliably prevent recurrence

  • persistent symptoms should be attributed to stress without further assessment

Stress and gut–brain interaction may amplify symptoms even after microbial overgrowth has resolved. This is another reason symptom recurrence should not automatically trigger another antimicrobial protocol.

The aim is not to tell you to relax.

It is to determine whether stress physiology appears to be one part of your presentation rather than using it as a default explanation.

Why repeating antimicrobials may not be enough

Antibiotics, herbal antimicrobials and elemental diets may reduce SIBO in appropriately selected patients.

But treatment response is variable, and the overall evidence base remains limited by small studies and inconsistent diagnostic methods. A recent meta-analysis found that antibiotics improved symptoms more often in tested SIBO patients than in those without SIBO, while also noting the limited quality of available trials.

When symptoms return, the next step should consider:

  • Whether SIBO or IMO was adequately confirmed

  • Whether the original treatment produced a meaningful response

  • Whether constipation remained unresolved

  • Whether another condition could be producing the symptoms

  • Whether the original breath-test pattern has changed

  • Whether medication or medical history affects motility

  • Whether dietary restriction has become part of the problem

  • Whether another round of treatment is clinically justified

Repeating treatment without reassessing the diagnosis can increase cost, food restriction and frustration without improving the long-term result.

Woman standing in kitchen thinking

Diet can reduce symptoms without preventing recurrence

A low-FODMAP or reduced-fermentation diet may temporarily reduce bloating, gas and abdominal discomfort.

That does not necessarily mean it has removed the overgrowth or addressed the reason symptoms returned.

Evidence for dietary treatment specifically eradicating SIBO or preventing recurrence remains limited. Low-FODMAP research is much stronger for IBS symptom management than for SIBO itself.

When a low-FODMAP approach is used, it should generally progress through:

  1. A time-limited reduction phase

  2. Structured reintroduction

  3. A personalised long-term diet

Long-term restriction is not the intended endpoint.

It is important to emphasise not becoming excessively rigid with dietary rules and remaining open to reintroductions after symptom control.

I pay particular attention to whether repeated SIBO treatment has left someone:

  • Afraid to reintroduce foods

  • Eating an increasingly narrow diet

  • Losing weight unintentionally

  • Struggling to meet fibre or energy needs

  • Interpreting every food reaction as bacterial regrowth

The long-term aim is the broadest diet you can comfortably and safely tolerate, not permanent restriction.

A clearer way to reassess recurrent SIBO symptoms

I look at what happened before, during and after treatment, not only at the symptoms you have today.

The aim is to determine whether the original overgrowth persisted, genuinely returned or is no longer the best explanation.

01 — Review the original diagnosis
Previous breath testing, symptom pattern, test preparation and whether SIBO or IMO was adequately established.

02 — Assess the treatment response
What treatment was used, how much you improved, which symptoms remained and how long the improvement lasted.

03 — Clarify what is happening now
Whether the current pattern suggests recurrence, unresolved constipation, another digestive condition or the need for further investigation.

04 — Build the next-step plan
Retesting, treatment, motility or bowel support, food reintroduction and referral are considered only where they are likely to change care.

The purpose is not to manufacture an elaborate list of root causes. It is to determine what is most likely happening now and which next step would materially change care.

You do not need another breath test before booking

You can begin with an initial consultation when symptoms have returned, previous treatment did not work as expected or you are unsure whether SIBO is still the best explanation.

You can book if:

  • SIBO or IMO has returned more than once

  • Symptoms improved and then gradually returned

  • Previous treatment did not work as expected

  • Constipation or bloating remains unresolved

  • Your diet has become increasingly restricted

  • You are unsure whether another test is necessary


Bring any previous:

  • Breath-test reports

  • Treatment plans

  • Medication or supplement lists

  • Pathology results

  • Imaging or specialist correspondence

I can review what has already been done and help determine whether repeat testing is likely to influence the next decision.


Testing should narrow the next decision, not simply add another result to the folder.

What a recurrence plan may involve

Recommendations depend on whether the current presentation appears to reflect persistent overgrowth, genuine recurrence or another digestive concern.

The aim is not to guarantee that SIBO will never return.

It is to reduce preventable recurrence, avoid unnecessary repeated treatment and provide a clearer plan if symptoms change again.


Reassessing the current pattern

Repeat breath testing where useful, review of hydrogen and methane results, and treatment directed by clinically relevant findings.

Bowel function and motility

Constipation support, selected motility strategies, practical meal timing and review of medicines that may affect transit.

Broader assessment and collaboration

Consideration of overlapping IBS or gut–brain interaction, pelvic-floor referral, gastroenterology assessment or collaboration with your GP where needed.

Nutrition and food tolerance

Nutritional support following prolonged restriction, gradual food reintroduction and review of relevant nutrient concerns.

A clearer next step

When digestive symptoms return, it is tempting to repeat the last treatment immediately.

A more useful first step is to clarify whether the overgrowth persisted, genuinely recurred or is no longer the best explanation for the symptoms.

That distinction can prevent repeated protocols, unnecessary dietary restriction and further investment in testing that does not change the plan.

Consultations are available in Maroochydore and at Kunara Marketplace in Forest Glen on the Sunshine Coast, as well as by telehealth throughout Australia.

Learn more about SIBO symptoms, testing and treatment support